LILRA3 Antibody (YA7115)
LILRA3 Antibody (YA7115) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to LILRA3.
-
Host:
Mouse
-
Isotype:
IgG1
-
Application:
FC, ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in PBS with 0.05% sodium azide
-
Conjugation:
Non-conjugated
Applications
| Application |
FC
FC: Flow Cytometry
|
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|
| Dilution Ratio | 1:200-1:400 | 1:10000 |
Product Details
LILRA3 Antibody (YA7115) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to LILRA3.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
-
Calculated Molecular Weight Predicted band size: 47.5kDa;
SwissProt: SwissProt: Q8N6C8
Purified recombinant fragment of human LILRA3 (AA: 24-168) expressed in E. Coli.
Endogenous
affinity purified.
Non-conjugated
Unmodified
IgG1
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in PBS with 0.05% sodium azide
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
LILRA3 acts as a soluble receptor for class I MHC antigens. Binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2. Binds with high affinity to the surface of monocytes, leading to abolish LPS-induced TNF-alpha production by monocytes
-
Subcellular Localization
Secreted
-
Expression
Tissue_Specificity: Detected in B-cells, and at lower levels in natural killer (NK) cells. Detected in peripheral blood monocytes and lung -
Isoforms & Post-Translational Modification
Q8N6C8 has three isomers: Q8N6C8-1: 47472 Da (predicted); Q8N6C8-2: 40357 Da (predicted); Q8N6C8-3: 49187 Da (predicted).
N-glycosylation is required for ligand binding -
SwissProt ID
Documentation